XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

Medical firm Getinge jumps as rising orders fuel profit beat



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-Medical firm Getinge jumps as rising orders fuel profit beat</title></head><body>

Adds share move in paragraph 2, analyst comment in -7

By Greta Rosen Fondahn

July 18 (Reuters) -Swedish medical equipment maker Getinge GETIb.ST beat second-quarter earnings forecasts on Thursday as its order intake rose despite some problems with its packaging and heart products.

The company's shares were up 7% in early Stockholm trading.

Getinge's earnings before interest, tax and amortisation (EBITA), adjusted for items affecting comparability, were 981 million Swedish crowns ($93 million) in the quarter, almost double the 495 million crowns reported a year earlier.

That beat analysts' consensus forecast of 829 million crowns, according to company-provided data.

Getinge has struggled to resolve quality problems with its heart pumps and with sterile packaging of products for heart-lung support systems, which has squeezed its margins and weighed on its shares since the second quarter of last year.

JPMorgan said Getinge's Acute Care Therapies (ACT) segment - its biggest business area that makes heart and intensive care products - drove the earnings beat, despite the quality issues.

"ACT performance is blow-out vs earlier commentary from the company," the brokerage said in a note to clients.

In May, Getinge said it would pause promotional activities and limit sales for some of its heart products in the United States, after the U.S. Food and Drug Administration (FDA) advised healthcare facilities to move away from the devices.

"We have accelerated improvement measures and the schedule for the next generation of these products," CEO Mattias Perjos said in a statement, adding it was too early to note any sales trend in the short term.

The maker of products for surgery, intensive care and sterilisation said its orders rose 7.8% organically in April-June to 8.41 billion crowns.

($1 = 10.5502 Swedish crowns)



Reporting by Greta Rosen Fondahn in Gdansk; Editing by Milla Nissi and Mark Potter

</body></html>

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.